UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	October 11, 2024 4:45 P.M.

Form:	S-4
CIK: 0001541157 Company Name: Akari Therapeutics Plc File Number: 333-282127